MACK

Merrimack Pharmaceuticals, Inc

1 day chart

About MACK

Merrimack Pharmaceuticals, Inc. is a biopharmaceutical company. The Company does not have any ongoing research or development activities and is seeking potential acquirers for its remaining preclinical and clinical assets. The Company is entitled to receive contingent payments related to its sale of ONIVYDE to Ipsen S.A. and also its contingent payments related to its sale of MM-121 and MM-111 to Elevation Oncology, Inc. Its payments are payable by Ipsen upon approval by the United States Food and Drug Administration (FDA) of ONIVYDE for certain additional clinical indications. ONIVYDE is approved by the FDA in combination with fluorouracil (5-FU) and leucovorin (LV) for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy. The Company’s wholly owned subsidiaries include Merrimack Pharmaceuticals UK Limited and Merrimack Securities Corporation.

Buy US stocks in Australia starting with MACK. Open an account and start investing today!

Market Capitalisation

$177.01M

Price-earnings ratio

Dividend yield

0.00%

Volume

22.14K

High today

$12.44

Low today

$12.31

Open price

$12.44

52-week high

$13.66

52-week low

$3.00

MACK FAQs

Can I buy MACK shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy MACK shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Merrimack Pharmaceuticals, Inc?

One share of Merrimack Pharmaceuticals, Inc is valued at $12.08.

What is the ticker symbol for Merrimack Pharmaceuticals, Inc?

The ticker symbol for Merrimack Pharmaceuticals, Inc is MACK.

How do I buy MACK shares in Australia?

To buy MACK stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in MACK

What is the 52-week high for Merrimack Pharmaceuticals, Inc stock?

The Merrimack Pharmaceuticals, Inc 52-week high stock price is $13.66.

What is the 52-week low for Merrimack Pharmaceuticals, Inc stock?

The Merrimack Pharmaceuticals, Inc 52-week low stock price is $3.00.

What is the market capitalisation of Merrimack Pharmaceuticals, Inc MACK?

As of 27/09/2023 Merrimack Pharmaceuticals, Inc has a market cap of $177M.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.